Dengue Virus-Associated Hemophagocytic Syndrome and Dyserythropoiesis: A Case Report  by Lu, Po-Liang et al.
Kaohsiung J Med Sci January 2005 • Vol 21 • No 1
P.L. Lu, H.H. Hsiao, J.J. Tsai, et al
34
DENGUE VIRUS-ASSOCIATED HEMOPHAGOCYTIC
SYNDROME AND DYSERYTHROPOIESIS: A CASE REPORT
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A 33-year-old man had dengue hemorrhagic fever with initial presentation of fever, leukocytosis, and
thrombocytopenia. The cause of the subsequent rapid decline in red cell counts without evidence of
intravascular hemolysis or massive bleeding was confirmed as hemophagocytosis and dyserythropoiesis
by bone marrow study. The patient recovered with supportive care and the bone marrow pattern was
normal on repeated bone marrow study. To our knowledge, this is the first reported case of dengue virus-
associated hemophagocytosis and dyserythropoiesis in Taiwan. Clinicians should consider that the
occurrence of hemophagocytosis and dyserythropoiesis could be due to dengue virus infection. That this
dengue virus infection was confirmed by a positive serology result at the convalescent stage but not at
the acute symptomatic stage underlines the need for a second dengue serology study, as dengue infection
can be missed due to an initial negative serology result.
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Dengue fever caused by dengue virus is an important
mosquito-transmitted disease due to its increased world-
wide incidence and its related complications [1]. The most
common manifestations of dengue virus infection are self-
limiting high fever and musculoskeletal pain. Some cases
may present with severe bleeding or even shock that is
classified as dengue hemorrhagic fever (DHF) [1].
Early neutropenia, with subsequent lymphocytosis and
a decrease in platelet count, and markedly hypocellular
marrow with abnormal megakaryocytopoiesis in the early
stage are common hematologic presentations of dengue
infection [2]. Several observations have been made on
changes in the bone marrow of patients with dengue fe-
ver and DHF [2–16]. However, there are few reports with
detailed studies of marrow aspirates throughout the course
of the disease [6].
Hemophagocytosis is an uncommon presentation of den-
gue infection. The cause of the exceptional hematopoietic
response of some patients to viral infections remains obscure,
but this response raises the distinct possibility of host factors
of which we are not aware [2]. We describe a patient with
DHF who developed hemophagocytosis and dyserythro-
poiesis and recovered. We also review previously reported
bone marrow findings during dengue infection.
CASE PRESENTATION
A 33-year-old Chinese male patient had had fever and chills
associated with general muscle soreness, headache, and
lower back pain since November 6, 2002. He came to the
emergency room of our medical center on November 10,
2002 because his fever did not subside after primary man-
agement. He also had abdominal pain, poor appetite, and
diarrhea for 2 days. Physical examination revealed pete-
chiae over both lower legs and splenomegaly.
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Laboratory examination on admission showed a white
blood cell (WBC) count of 24,820/mm3, red blood cell
(RBC) count of 5,580,000/mm3, hemoglobin of 18.2 g/dL,
hematocrit of 53.0%, and platelet count of 4,000/mm3.
Differential leukocyte count showed a predominance of
polymorphonuclear cells (segmented, 67%; band, 8%;
lymphocytes, 8%; monocytes, 15%; normoblasts, 1%). The
aspartate transaminase concentration was 179 U/L, alanine
transaminase concentration was 88 U/L, blood urea nitrogen
was 22 mg/dL, creatinine concentration was 1.0 mg/dL,
glucose concentration was 115 mg/dL, C-reactive protein
level was 0.4 µg/mL, prothrombin time (PT) was 12/10.9
seconds (case/control), activated partial thromboplastin
time (APTT) was 50.3/30.4 seconds (case/control), hapto-
globulin concentration was less than 5.83 mg/dL (nor-
mal, 13–163 mg/dL), Coombs’ test (direct and indirect) was
negative, and lactate dehydrogenase level was 1,243 U/L
(normal, 180–460 U/L). The stool occult blood test result
was 4+.
At 2 days after admission, WBC count had decreased
to 16,890/mm3, hemoglobin level to 12.0 g/dL, hematocrit
to 35.8%, and platelet count to 1,600/mm3. Over a 6-day
period (November 10–15), the WBC count dropped to
5,160/mm3, the RBC count to 4,020,000/mm3, and the
hemoglobin to 12.4 g/dL. Routine urine tests on the 6th
day revealed no pyuria and no hematuria, but dipstick tests
were positive for bilirubin (1+) and urine protein (1+). The
reticulocyte index was 0.45%. The patient had a positive
result for hepatitis B surface antigen and a negative result
for hepatitis C antibody. Tests for heterophil antibody and
cytomegalovirus immunoglobulin (Ig) M were negative,
while that for Epstein-Barr virus nucleus antigen antibody
was positive. Antinuclear antibody was absent. Blood cul-
ture on admission was negative for bacteria. Abdominal
sonography 7 days after admission showed bilateral pleu-
ral effusion, ascites, splenomegaly, gall bladder sludge,
and gall bladder wall thickening. Chest roentgenography
revealed bilateral lower lung pleural effusion.
Bone marrow was examined on the 9th day after fever
because of marked leukocytosis and the rapid decrease in
hemoglobin and platelet count. Marrow aspiration showed
normal cellularity (50%) with adequate megakaryocytes
and normal myeloid differentiation. However, dyserythro-
poiesis syndrome (nucleus budding, multiple nuclei, and
some megaloblastic change) and hemophagocytosis were
found (Figure 1).
The patient received supportive care without anti-
microbial therapy. His fever subsided on the 10th day after
symptoms appeared. He was discharged on the 10th hospi-
Figure 1. Initial bone marrow examination shows: (A) normal cellularity
with erythroid hyperplasia and megaloblastoid erythropoiesis (arrow);
(B) hemophagocytosis (arrowhead). (C) The nuclear budding and
multinucleation characteristics of dyserythropoiesis are clearly seen
under high-power magnification (× 1,000).
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talization day when the fever had subsided and the WBC
count was 4,760/mm3, hemoglobin was 12 g/dL, and platelet
count was 77,000/mm3. Dengue virus serology by enzyme-
linked immunosorbent assay, performed by The Center
for Disease Control, Taiwan, 6 days after onset of fever and
symptoms, was negative for IgG and IgM antibodies to
dengue virus [17]. Convalescent serology tests on Novem-
ber 23 and December 20 were positive for IgG and IgM anti-
bodies to dengue virus, confirming the dengue virus infec-
tion. According to his clinical manifestations, the patient
was diagnosed as having DHF: his diagnostic criteria were
acute febrile illness, bleeding symptoms or signs, throm-
bocytopenia (< 105 cells/µL), and evidence of plasma leak-
age (pleural effusion, ascites) [1].
Follow-up examination 1 month later showed no
sequelae. The laboratory data were as follows: WBC,
9,820/mm3; hemoglobin, 13.6 g/dL; hematocrit, 43.4%;
platelet count, 266,000/mm3; PT, 11.5/12.1 seconds; and
APTT, 31.8/29.8 seconds. Repeated bone marrow aspira-
tion showed recovery to a normal marrow pattern and dis-
appearance of dyserythropoiesis (Figure 2).
DISCUSSION
Infection with dengue virus commonly produces neutro-
penia with lymphocytosis and thrombocytopenia [18].
Hematocrit, hemoglobin, PT, and APTT are normal in un-
complicated classical dengue fever, but they may alter in
dengue fever complicated with severe hemorrhage [19].
Our case lacked the characteristic leukopenia of adult
dengue. Leukopenia (< 5,000/mm3) is found in most non-
shock cases of dengue infection [7]. Only 16% of mild cases
have leukocytosis, which appears during the recovery stage,
whereas 67% of shock cases and 66% of mortality cases have
pronounced leukocytosis [20]. Clinically, leukocytosis is an
ominous sign for dengue infection [20]; our DHF case had
this hematologic finding.
The longer survival of erythrocytes compared with
platelets and granulocytes makes the hematocrit relatively
insensitive to modest or temporary changes in either RBC
production or survival [21]. There was no clinical evidence
of intravascular hemolysis and no massive bleeding clini-
cally in our case; bone marrow aspiration showed that
the sudden and significant fall in RBC counts resulted from
intramedullary destruction of blood cells by hemophago-
cytic histiocytes.
Bone marrow aspiration is not a usual procedure for
dengue infection cases, mostly due to the risk of bleeding
and because most patients have classic dengue fever, where
changes in blood cell counts recover.
Thrombocytopenia is often seen among dengue-infected
patients. Hemophagocytosis is regarded as one of the causes
of thrombocytopenia [9,22]. Other processes that interfere
with platelet cells, acting successively or in combination,
are: early transient marrow suppression with damage to
megakaryocytes [23]; platelet aggregation with endothe-
lial cells targeted by dengue viruses [24]; and immune
destruction of platelets, with dengue antibody complexes
found on membranes [25].
Figure 2. Bone marrow examination at follow-up: (A) nearly normal marrow with a myeloid:erythroid ratio of 3.5:1 (× 400); (B) disappearance of
the dyserythropoiesis (× 1,000).
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In dengue-infected patients, bone marrow hypoplasia
is typical [2]. Dengue infection of hematopoietic cells is
not cytotoxic but slows cell proliferation [26]. Erythroid pro-
genitor colonies from dengue-infected cultures are smaller
and abnormally dispersed [26,27]. Dyserythropoiesis
shows as erythroid hyperplasia with arrest of maturation [5].
Dengue-related hemophagocytosis has been described
in the literature [6,9–13]. The self-limiting hemophago-
cytosis syndrome with supportive care in our case follows
a similar disease process to other surviving dengue-
associated hemophagocytosis cases [21–23] and most
reactive hemophagocytosis cases [28]. However, most re-
ported cases of hemophagocytic syndrome are DHF cases
and from postmortem bone marrow study [6,14,22,24].
Nelson et al proposed that hemophagocytosis was present
in the terminal stage of dengue infection because seven
postmortem cases and two severe cases (one with prolonged
shock and one with severe epistaxis) had variable levels of
hemophagocytosis [6], while no hemophagocytosis was
found in another 22 bone marrow samples from dengue
fever cases [7]. In contrast, two postmortem bone marrow
studies in 12 and 100 DHF cases, respectively, did not find
features of hemophagocytosis [14,15]. A causal relationship
between hemophagocytosis and the severity of dengue
infection has been suggested [6] but not fully established.
Other studies on bone marrow in dengue-infected cases did
not find hemophagocytosis, which shows that hemophago-
cytosis is not a common presentation of dengue infection
[5,2,16].
The initially negative dengue serology result and the
concurrent bone marrow finding of hemophagocytosis and
dyserythropoiesis might lead to a diagnosis of myelodys-
plastic syndrome or hemophagocytosis, including malig-
nant histiocytosis, which may require a different treatment.
Our case had reactive hemophagocytosis, which may occur
during dengue infection, and confirmed reversible bone
marrow changes after infection. Clinicians should consider
the possibility that hemophagocytosis could be a compli-
cation of dengue infection, which requires bone marrow
aspiration and second serology study for dengue virus at
the recovery stage.
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